Cross Border

Covid-19 vaccine: Pfizer's Moon Shot

Covid-19 vaccine: Pfizer's Moon Shot

Training customer reps to be better humans

Training customer reps to be better humans

Covid-19: How optimism raked returns for this Scottish money manager

Covid-19: How optimism raked returns for this Scottish money manager

The man getting America back on track

The man getting America back on track

Akshay Kumar again the only Indian on the Forbes Celebrity 100 list for 2020

Akshay Kumar again the only Indian on the Forbes Celebrity 100 list for 2020

  • Winning by not losing

    Winning by not losing

    Even before the pandemic sent markets tumbling, Advent Capital's Tracy Maitland was prepared for the mayhem. In good times, his portfolio tracks the market, but during downturns it's a refuge from the storm

  • Quibi: The billionaire's startup

    Quibi: The billionaire's startup

    The world is awash in streaming services, and Meg Whitman already had her fortune—but then Jeffrey Katzenberg came calling with a mobile-focussed startup. With nearly $1.8 billion raised and America on lockdown, consumers may have no choice but to try Quibi

  • The oil man and the sea

    The oil man and the sea

    Kjell Inge Rokke amassed a $1.7 billion fortune by stripping the oceans of oil and fish. Now he says he wants to clean up the mess—from the deck of the world's largest superyacht. Meet the biggest contradiction on water

  • The tiny battery powering Airpods built a $1.9 bn fortune

    The tiny battery powering Airpods built a $1.9 bn fortune

    Thirteen years ago, no one wanted to buy a money-losing hearing-aid battery maker. No one but Michael Tojner. Against all odds, Austria's 'Mr 300 percent' turned that $40 million investment into a $1.9 billion fortune (thank you, Apple!). Now he has to fend off the copycats

  • Bitcoin's guardian angel: Coinbase's Brian Armstrong's quest for trust

    Bitcoin's guardian angel: Coinbase's Brian Armstrong's quest for trust

    For now, Coinbase looks like a casino, but its billionaire founder, Brian Armstrong, sees it as just the beginning of the financial liberation of the planet

  • Why Gates and Zuck think the next drug blockbusters will come from your gut

    Why Gates and Zuck think the next drug blockbusters will come from your gut

    On the bravest frontier in human health, scientists are using bacteria from the digestive system to create novel medicines for a huge range of ailments including Parkinson's, cancer and autism. The results could transform lives and deliver massive returns for early investors

  • The optometrist who beat the odds to become a billionaire

    The optometrist who beat the odds to become a billionaire

    Amid stock market booms and busts, and game-changing innovations from ETFs to algorithmic trading, a Florida optometrist could be the greatest inventor you never heard of

  • Elon's new nemesis

    Elon's new nemesis

    Check your rearview mirror, Tesla. Rivian has a $3 billion war chest from Amazon, Ford and the Saudis, and is revving up production on its electric SUVs and trucks. Now all the secretive automaker has to do is start building cars and avoid the roadblocks that almost caused Tesla to crash. A rare interview with its 37-year-old founder, RJ Scaringe

  • The James Bond of Burgundy

    The James Bond of Burgundy

    Winemaker Jean-Charles Boisset has stealthily built a $450 million oenological empire in France and California, one struggling vineyard at a time—and uncorked a lascivious secret-agent persona

  • KR Sridhar's bloom and bust story

    KR Sridhar's bloom and bust story

    The Forbes Investigation: How Bloom Energy blew through billions promising cheap, green tech that falls short

  • Long live email?

    Long live email?

    The inbox had been left for dead. Now it's being resurrected by the two founders of Front, a startup with big-name backers and a mission to make old-fashioned email cutting-edge again

X